XPC deficiency has also been associated with inhibition of BRCA1 expression on bladder cancer cells treated with cisplatin, resulting in accumulation of DNA damage and pointing to a potential indirect role of XPC in homologous recombination or, more likely, replication-induced double strand breaks (62). This evidence concerns the gene XPC and urinary bladder carcinoma.